Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database.
Roger M. Mills(Janssen (Belgium)), Robert C. Bourge(University of Alabama at Birmingham), James K. Kirklin(Kirklin Clinic), Howard J. Eisen(Thomas Jefferson University), Edward K. Massin, B. Jaski, David C. Naftel(University of Alabama at Birmingham), Forrester A. Lee, Daniel P. Fishbein, Adrian B. Van Bakel
PubMed
August 1, 1997
Cited by 144
Related Papers
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease
|New England Journal of Medicine|1976|480
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure
|Journal of the American College of Cardiology|1999|323
Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis
|New England Journal of Medicine|2003|278